The biotechnology industry uses advances in genetics research to develop products for human diseases and conditions. This section includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.
Cancer: Using cell metabolism to fight stubborn tumors
Targeting cell metabolism could stop cancer cells from using a survival mechanism called autophagy to escape treatment and seed new tumors, says new study.
What are the side effects of antibiotics?
Doctors prescribe antibiotics to treat bacterial infections. However, they can cause side effects, such as digestive issues, fungal infections, and drug interactions. Some people experience severe reactions, including anaphylaxis and antibiotic resistant infections. Learn about the side effects of antibiotics here.
Experimental drug may treat 'undruggable' cancers
Researchers have found a way to block a cell signaling pathway that is common to many hard-to-treat cancers and has so far defied attempts to target it.
Can you mix cephalexin and alcohol?
Cephalexin, also spelled cefalexin, is an antibiotic. It belongs to a class of antibiotics known as first-generation cephalosporins, which doctors use to treat a range of bacterial infections. While some antibiotics are not safe to take when consuming alcohol, cephalexin does not usually cause adverse reactions.
Cancer cells are weaker when made more acidic
New research suggests that making the insides of cancer cells more acidic upsets their metabolism. This vulnerability could offer new therapy targets.
New antibiotic found in common weed
Researchers have found a new type of antibiotic on the leaf of a common weed and suggest that this little-explored ecosystem could yield many new drugs.
Blocking one enzyme could help treat many chronic disorders
New drugs for diverse inflammatory diseases — from Alzheimer's and Parkinson's to cancer and osteoarthritis — may come from the discovery of a new target.
Commonly used yeast could cause drug-resistant infections
A yeast that has been used in industry for hundreds of years has recently been identified as the exact same species that causes drug-resistant infections.
Potential new MS drug could regenerate myelin
A study finds that blocking the M3R receptor improves myelination in mice implanted with human progenitor cells, maybe leading to clinical trials in MS.
How to get rid of an amoxicillin rash
A reaction to amoxicillin, a medication used to treat bacterial infections, causes an amoxicillin rash. A side effect of amoxicillin can be a rash that may be mild or severe. Treatment options include medication, applying oatmeal to the rash, and drinking plenty of water. Learn more about an amoxicillin rash here.
Cancer: 'Intelligent drug delivery' is on its way
Scientists have demonstrated a precision targeting system that only releases anticancer drugs when it encounters two tumor conditions in the right order.
Prostate cancer: New drug for aggressive, resistant cases
Enzalutamide reduced metastasis or death risk by 71 percent in phase III trial of castration-resistant nonmetastatic prostate cancer with escalating PSA.
Could blocking these proteins stop breast cancer?
A study suggests that blocking certain epigenetic proteins with drugs could prevent women at high risk of breast cancer from developing the disease.
Type 2 diabetes: New pill could 'mimic the effects of surgery'
A material that temporarily coats the small intestine and can be taken in pill form before a meal reduced glucose response by 47 percent in rats.
This 'light-activated' drug could treat Parkinson's
A drug activated in the brain using light delivered by implanted optical fiber improved motor function and reduced Parkinson's symptoms in mice.
Atherosclerosis: Could there be a best time of day for medication?
New research finds that the biological processes of atherosclerosis vary according to time of day and may have implications for timing of medication.
Keep up on the latest news from VMS BioMarketing. Links to featured news releases are posted below.
VMS BioMarketing Launches New Corporate Website
Posted on Tuesday June 05, 2018
New website provides practical solutions to challenges of medication adherence
VMS to Sponsor Oncology Nursing Society 'Mara' Lecture Addressing Topics Related to the Psychosocial Aspects of Cancer
Posted on Tuesday May 15, 2018
VMS BioMarketing Clinical Educators Gear Up to Help Reduce HIV Risks
Posted on Wednesday May 02, 2018
Healthcare provider education aimed at preventing opioid-related HIV outbreaks
VMS BioMarketing Clinical Nurse Educators Will Provide Education to Support Needs of Women With Breast Cancer
Posted on Wednesday October 11, 2017
VMS BioMarketing Named a Best Workplace for Giving Back by Fortune Magazine and Great Place to Work®
Posted on Wednesday September 20, 2017
VMS has experienced more than two decades of success by strategically partnering with our clients to continually provide best-in-class service. We have been recognized for our key contributions and impressive growth.
For the third consecutive year, rated a Great Place to Work® by the experts who produce FORTUNE's 100 Best Companies to Work For® list